Table 2.
Characteristics of 4,790 veterans hospitalized with SARS-CoV-2 positive tests
| White | Black | Hispanic | American Indian or Alaska native | Asian | Unknown | |
|---|---|---|---|---|---|---|
| N (%) | 1,915 | 2,138 | 432 | 39 | 31 | 235 |
| Age [years], mean (SD) | 71.8 (13.4) | 66.9 (12.5) | 63.0 (16.5) | 60.7 (20.3) | 66.3 (14.5) | 67.8 (16.1) |
| BMI [Kg/m^2], mean (SD) | 29.4 (7.3) | 29.5 (7.2) | 30.2 (6.8) | 27.7 (5.8) | 29.9 (6.3) | 28.2 (6.4) |
| Gender [number Male], N (%) | 1829 (96) | 2015 (94) | 412 (95) | 36 (92) | 29 (94) | 223 (95) |
| Length of stay [days], mean (SD) | 12.1 (11.9) | 11.3 (11.5) | 10.3 (10.6) | 10.1 (7.8) | 11.9 (11.1) | 11.2 (10.6) |
| ICU admission, n (%) | 795 (41.5) | 919 (43.0) | 181 (41.9) | 18 (46.2) | 15 (48.4) | 87 (37.0) |
| In-hospital mortality, n (%) | 337 (17.6) | 331 (15.5) | 64 (14.8) | 6 (15.4) | 7 (22.6) | 33 (14.0) |
| Comorbidities and preexisting conditions* | ||||||
| Elixhauser comorbidity index, mean (SD) | 13.4 (14.2) | 12.8 (13.8) | 9.2 (12.0) | 6.1 (9.0) | 13.0 (12.6) | 9.6 (12.9) |
| Congestive heart failure, N (%) | 371 (19) | 366 (17) | 61 (14) | 3 (8) | 5 (16) | 26 (11) |
| Coronary atherosclerosis and other heart disease, N (%) | 673 (35) | 545 (25) | 120 (28) | 11 (28) | 9 (29) | 52 (22) |
| Cardiomyopathy, N (%) | 134 (7) | 175 (8) | 26 (6) | 4(10) | 1 (3) | 12 (5) |
| Cancer, N (%) | 513 (27) | 652 (30) | 90 (21) | 9 (23) | 5 (16) | 44 (19) |
| Chronic kidney disease, N (%) | 498 (26) | 700 (33) | 80 (19) | 6 (15) | 7 (23) | 56 (24) |
| Chronic obstructive pulmonary disease, N (%) | 596 (31) | 489 (23) | 68 (16) | 6 (15) | 10 (32) | 37 (16) |
| Obesity (BMI ≥ 30), N (%) | 149 (8) | 175 (8) | 40 (9) | 2 (5) | 2 (6) | 8 (3) |
| Sickle cell disease, N (%) | 1 (0) | 14 (1) | 1 (0) | 0 (0) | 0 (0) | 0 (0) |
| Diabetes type 2, N (%) | 881 (46) | 1115 (52) | 200 (46) | 16 (41) | 23 (74) | 82 (35) |
BMI body mass index, *Comorbidities and preexisting conditions estimated for 2 years prior to positive test date